America Just Got Its First New Sunscreen Filter in 25 Years

On June 9, 2026, the FDA did something it had not done in about 25 years: it approved a brand-new sunscreen filter for the American market. The ingredient is bemotrizinol, which you may know by its European trade name, Tinosorb S. If you’ve ever wondered why a French pharmacy sunscreen feels so much nicer than its American cousin, this approval is a piece of that answer finally falling into place.

Here’s the detail that tells the whole story. Bemotrizinol has been in European, Australian, and Asian sunscreens since the year 2000 (Consumer Reports on the FDA approval). A quarter of a century of use, on multiple continents, on millions of bodies, before an American could legally buy it in a drugstore. So let me walk through what actually happened, what this filter does, and, in the calibrated spirit of this site, what it does not magically fix.

What the FDA actually did

The mechanics matter, because they explain the delay. The FDA issued a Final Administrative Order (OTC000039) adding bemotrizinol as a permitted active ingredient in over-the-counter sunscreens. The order takes effect on August 9, 2026, which means products containing it could start reaching US shelves as early as that August (CIRS Group regulatory summary).

This is the first new active ingredient added to the US OTC sunscreen monograph since the late 1990s. That “since the 1990s” caveat is worth being precise about, because precision is the brand here. A couple of filters did reach the US in the intervening years through a different, narrower drug-approval route tied to specific products. But the monograph, the general list of filters any manufacturer can use, had been frozen for about a generation. Bemotrizinol is the first to break that freeze.

Why it took 25 years (the regulatory part)

The reason isn’t that bemotrizinol was under a cloud of suspicion. It’s a quirk of how the US classifies sunscreen.

In Europe, sunscreens are regulated as cosmetics. A new UV filter goes through a safety review by the Scientific Committee on Consumer Safety and, if it passes, gets added to the approved-filter annex. Workable, and relatively quick.

In the United States, sunscreens are regulated as over-the-counter drugs. That sounds more rigorous, and in some ways it is, but it created a bottleneck. For years, getting a new filter onto the US monograph required clearing a drug-grade evidence bar through a process that, in practice, stalled. Eight filters used freely in other countries sat in an FDA queue for over a decade, including bemotrizinol. The 2020 CARES Act and the later sunscreen-innovation reforms were meant to unclog this exact pipe. Bemotrizinol’s 2026 approval is the first real product of that unclogging.

So the honest framing of the “gap” is not that America was protecting its citizens from a risky chemical. It’s the reverse. A filter the rest of the developed world judged safe and useful was kept out by an administrative process that couldn’t move, and Americans were left with a smaller, older toolkit as a result.

What bemotrizinol actually does

Now the part that matters for your skin. Bemotrizinol is an organic (chemical) filter, and its strength is breadth. It’s broad-spectrum, absorbing across both UVB, the wavelengths that burn you, and crucially UVA, the longer wavelengths that drive photoaging and contribute to skin cancer (Dr. Jane Yoo on bemotrizinol).

UVA coverage is exactly where the old American filter set was weakest. The US menu leaned heavily on avobenzone for UVA, and avobenzone is famously unstable: it degrades in sunlight unless carefully stabilized, which is the opposite of what you want from a thing whose entire job is to sit in sunlight. Bemotrizinol is both broad and photostable, and it even helps stabilize other filters in the same bottle. It also has very low percutaneous absorption, meaning little of it passes through the skin into the body, which is part of why regulators across several continents have been comfortable with it for decades.

Add it up and the practical promise is real: American formulators now have access to a filter that allows better, more stable UVA protection in cosmetically lighter formulas. The chalky, heavy, white-cast American sunscreen has a path to getting genuinely better.

What it does not fix (the calibration)

This is where I’ll gently push back on the celebration, because the takeaway shouldn’t be “American sunscreen was dangerous and now you’re saved.”

First, the sunscreen you already own works. US sunscreens have always blocked UVB well, which means they prevent sunburn, the most visible acute damage. The historical weakness was UVA range and formula elegance, not a failure to protect you at the beach this weekend. Don’t let “new filter” talk you into distrusting the bottle in your bathroom. The best sunscreen remains the one you’ll actually reapply.

Second, approval of an ingredient is not the same as products on shelves. The order takes effect in August 2026, and reformulating, testing, and manufacturing take time. Expect a trickle, then a wave, not an overnight transformation of the sunscreen aisle.

Third, one filter is not the entire European advantage. Europe’s edge comes from a whole palette of modern filters (bemotrizinol is one of a family that includes bisoctrizole, also known as Tinosorb M, and others still pending in the US). One approval narrows the gap. It doesn’t close it.

And fourth, a measured word on the older American filters this might replace. Filters like oxybenzone have drawn real scrutiny, and the EU restricts oxybenzone’s concentration rather than banning it. But “an alternative now exists” is a better reason to welcome bemotrizinol than “the old ones are poison,” which overstates the evidence. More choices, better UVA stability, lighter textures. That’s the honest case, and it’s a good one without the fear.

The bigger picture

I find this story satisfying because it’s the mirror image of most of what this site covers. Usually the pattern is: Europe restricts something on precaution, the US allows it, and the open question is whether America is being reckless. Sunscreen flips the script. Here Europe (and Australia, and Asia, and Canada) gave its citizens better tools, and the US lagged, not out of caution about a real danger, but because its regulatory plumbing seized up.

It also undercuts a lazy assumption, the one where “the EU is always the cautious nanny and the US is always the free-for-all.” Regulation isn’t a single dial running from strict to loose. It’s a set of different systems with different defaults, and each gets some things right and some things wrong. On UV filters, the US system, the one that treats sunscreen as a drug, produced 25 years of stagnation. On food dyes, the EU’s precautionary default moved faster. Same two governments. Opposite outcomes. That’s the texture the headlines flatten, and it’s the part worth holding onto.

So: good news, properly sized. America finally has a modern sunscreen filter the rest of the world has used since the turn of the millennium. Better protection is coming to a shelf near you. Just not tomorrow, and not because the old stuff was trying to hurt you.